#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia positive chronic myeloid leukaemia Glioma Scedosporium infection Progressive familial intrahepatic cholestasis Albright's disease Haemophilia A with anti factor VIII Endometrial cancer Small cell lung cancer limited stage Thalassaemia alpha Hereditary haemorrhagic telangiectasia Essential thrombocythaemia Cardiomyopathy Chronic lymphocytic leukaemia Diffuse large B-cell lymphoma refractory Prophylaxis against transplant rejection More trials…

    Learn about Rare Diseases

    Medulloblastoma SAPHO syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Basic Information Hereditary motor and sensory neuropathy – Basic Information Hepatoblastoma – Treatment Testicular leiomyosarcoma – Treatment Haemophilia B with anti factor IX – Trials in Disease Optic glioma – Life with Disease Antisynthetase syndrome – Diagnostics Lysosomal storage disorder – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ceftriaxone Jab-21822 Thiamine Nitrate Bp IG-TREGS Dexamfetamine Sulfate Istaroxime Iloprost Trometamol Mitazalimab Mk-0482 L-PROLINE Remifentanil Hydrochloride Brodalumab IHMA-2121771-1 Pioglitazone Hydrochloride Asfotase Alfa Romosozumab Kk8123 Aliskiren Gindameran ILOPROST More therapies…

    Learn about Your Condition

    Alcohol abuse Malignant mast cell neoplasm Lung neoplasm malignant Hypertriglyceridaemia Influenza Oesophagectomy Post procedural oedema Autoimmune uveitis Habitual abortion Chronic hepatitis B Arthritis infective Hyponatraemia Pseudoxanthoma elasticum Dyskinesia Hypotension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Vivantes Netzwerk fuer Gesundheit GmbH

Vivantes Netzwerk fuer Gesundheit GmbH

Landsberger Allee 49, Friedrichshain, Berlin, 10249, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Gilteritinib
    • Midostaurin
    Austria Belgium Finland France Germany Ireland +5

  • Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Procarbazine Hydrochloride
    • Dacarbazine
    • Brentuximab Vedotin
    Austria Denmark Germany The Netherlands Norway Sweden

  • Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epirubicin
    • Olaparib
    • Capecitabine
    Austria Belgium Bulgaria France Germany Hungary +3

  • Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Cyclophosphamide
    • Doxorubicin
    Austria Belgium Czechia France Germany Italy +3

  • Study on the Safety and Effectiveness of Giroctocogene Fitelparvovec for Adult Men with Moderate to Severe Hemophilia A

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Giroctocogene Fitelparvovec
    France Germany Greece Spain Sweden

  • Study on [68Ga]Ga-PentixaFor and [18F]FDG PET/CT Imaging for Staging Marginal Zone Lymphoma in Patients with Confirmed Diagnosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Marginal zone lymphoma
    Investigated Drugs:
    • Pentixafor
    • Fludeoxyglucose (18F)
    • Gallium (68Ga)
    Austria France Germany Italy Spain

  • Study on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Factor IX deficiency
    Investigated Drugs:
    • Fidanacogene Elaparvovec
    Belgium France Germany Greece Italy Spain +1

  • Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophilia
    Investigated Drugs:
    • Factor Viii Inhibitor Bypassing Fraction
    • Damoctocog Alfa Pegol
    • Fitusiran
    France Germany Greece Italy Poland Spain

  • Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Haemophilia B without inhibitors
    • Haemophilia A without inhibitors
    • Haemophilia A with anti factor VIII
    Belgium Bulgaria France Germany Italy Poland +1

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +14
Previous Page
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!